INOVIO Pharmaceuticals is a clinical-stage biotechnology company based in San Diego, CA, dedicated to developing innovative DNA medicines to combat HPV-related diseases, cancer, and infectious diseases. Their proprietary technology utilizes optimized design and delivery of DNA plasmids, which act as software for the body's cells to produce specific disease-fighting proteins. With a focus on scientific excellence and operational expertise, INOVIO aims to redefine treatment paradigms and improve lives globally.
Driven by cutting-edge technology and a commitment to patient well-being, INOVIO harnesses the power of DNA medicine to revolutionize healthcare. Their research and development efforts are centered on advancing next-generation therapies with groundbreaking potential, leveraging the versatility, immunogenicity, and scalability of DNA medicines. By utilizing their proprietary CELLECTRA delivery devices, INOVIO ensures optimal effect without the need for chemical adjuvants or nanoparticles, setting them apart from viral vector platforms and minimizing the risk of anti-vector response. Through their dedication to transforming treatment approaches, INOVIO is poised to make a significant impact in the field of biotechnology.
Generated from the website